Evidence map›Paper›PMID 34035489›Full record

ReviewEye (London, England)2021

Biocompatibility of intraocular liquid tamponade agents: an update.

Mario R Romano, Mariantonia Ferrara, Irene Nepita, Jana D'Amato Tothova, Alberto Giacometti Schieroni, Daniela Reami, Raniero Mendichi, Libero Liggieri, Rodolfo Repetto

Open access · bronzeAbstract readReview
In one paragraph

Review in Eye (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. A minimum specification dataset for liquid ocular endotamponades: recommendations by a European expert panel.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Editorial: Imaging in Ophthalmology.Journal of clinical medicine · 2022
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Mario R RomanoDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, Italy.ORCID http://orcid.org/0000-0003-0348-0532
Mariantonia FerraraNewcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK. mariantonia.ferrara@gmail.com.ORCID http://orcid.org/0000-0002-1191-4989
Irene NepitaDepartment of Civil, Chemical and Environmental Engineering, University of Genoa, Genoa, Italy.
Jana D'Amato TothovaResearch and Development, AL.CHI.MI.A. S.R.L.S.r.l., Ponte San Nicolò (PD), Italy.
Alberto Giacometti SchieroniCNR-Istitute for Chemical Sciences and Technology, Milano, Italy.ORCID http://orcid.org/0000-0003-1051-3750
Daniela ReamiRegulatory affairs AL.CHI.MI.A. S.R.L.S.r.l, Ponte San Nicolò (PD), Italy.
Raniero MendichiConsultant Polymers Characterization, Tribiano, Milano, Italy.
Libero LiggieriCNR-Institute for Condensed Matter Chemistry and Technologies for Energy (ICMATE), Genoa, Italy.
Rodolfo RepettoDepartment of Civil, Chemical and Environmental Engineering, University of Genoa, Genoa, Italy.
University of Genoa · ITHumanitas University · ITInstitute for the Science and Technology of Plasmas · ITInstitute of Condensed Matter Chemistry and Technologies for Energy · ITRoyal Victoria Infirmary · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intraocular liquids tamponade agents, such as perfluorocarbon liquids (PFCLs), semifluorinated alkanes (SFAs), silicone oils (SOs) and heavy silicone oils (HSOs), are a crucial intraoperative and/or postoperative tool in vitreoretinal surgery, in particular for the management of complex vitreoretinal diseases. However, their use is not without complications, which are potentially severe. Consequently, a growing interest has been devoted to the biocompatibility of these compounds and the adequacy of current regulations that should guarantee their safety. Obviously, an updated knowledge on research findings and potential risks associated to the use of intraocular liquid compounds is essential, not only for vitreoretinal surgeons, but also for any ophthalmologist involved in the management of patients receiving intraocular liquid tamponades. In light of this, the review provides a comprehensive characterisation of intraocular liquid tamponades, in terms of physical and chemical properties, current clinical use and possible complications. Moreover, this review focuses on the safety profile of these compounds, summarising the existing regulation and the available evidence on their biocompatibility.

Indexed as

FluorocarbonsRetinal DetachmentVitreoretinal SurgeryHumansSilicone OilsFluorocarbonsSilicone Oils

Identifiers

PMID34035489
PMCPMC8452761
OpenAlexW3165253473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.